Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease

Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease

Low high-density lipoprotein-cholesterol (HDL-c) is the most remarkable lipid trait both in mild-to-moderate chronic kidney disease (CKD) patients as well as in advanced renal disease stages, and we have previously shown that reduced lecithin:cholesterol acyltransferase (LCAT) concentration is a maj...

Full description

Bibliographic Details
Main Authors: Andrea Baragetti, Alice Ossoli, Arianna Strazzella, Sara Simonelli, Ivano Baragetti, Liliana Grigore, Fabio Pellegatta, Alberico L. Catapano, Giuseppe Danilo Norata, Laura Calabresi
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
lecithin:cholesterol acyltransferase
chronic kidney disease
high-density lipoproteins
Online Access:https://www.mdpi.com/2077-0383/9/7/2289

Internet

https://www.mdpi.com/2077-0383/9/7/2289

Similar Items